Top
image: shutterstock

Prescription drug monitoring programs come under fire

As the President’s Commission on Combating Drug Addiction and the Opioid Crisis prepares to issue its final report next week, one legal expert is sounding the alarm about the potential privacy risks from state databases that track prescriptions and the fact that they are expanding in size and scope.

The commission issued an interim report in late July recommending that the federal government provide funding and technical support to states to improve interstate data sharing between state-run prescription drug monitoring programs (PDMPs) to better track prescriptions written for addictive medications. PDMPs record a patient’s opioid prescribing history and are used to flag suspicious activity.

Read More on Health Data Management